360 related articles for article (PubMed ID: 25450026)
41. trans-Platinum(II) Thionate Complexes: Synthesis, Structural Characterization, and in vitro Biological Assessment as Potent Anticancer Agents.
Sakamaki Y; Ahmadi Mirsadeghi H; Fereidoonnezhad M; Mirzaei F; Moghimi Dehkordi Z; Chamyani S; Alshami M; Abedanzadeh S; Shahsavari HR; Beyzavi MH
Chempluschem; 2019 Oct; 84(10):1525-1535. PubMed ID: 31943935
[TBL] [Abstract][Full Text] [Related]
42. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
[TBL] [Abstract][Full Text] [Related]
43. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of anticancer activity of novel platinum(II) bis(thiosemicarbazone) complex against breast cancer.
Radomska D; Szewczyk-Roszczenko OK; Marciniec K; Książek M; Kusz J; Roszczenko P; Szymanowska A; Radomski D; Bielawski K; Czarnomysy R
Bioorg Chem; 2024 Jul; 148():107486. PubMed ID: 38788367
[TBL] [Abstract][Full Text] [Related]
45. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract][Full Text] [Related]
46. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
[TBL] [Abstract][Full Text] [Related]
47. Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs.
Piccinonna S; Margiotta N; Pacifico C; Lopalco A; Denora N; Fedi S; Corsini M; Natile G
Dalton Trans; 2012 Aug; 41(32):9689-99. PubMed ID: 22782180
[TBL] [Abstract][Full Text] [Related]
48. Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives.
Serratrice M; Maiore L; Zucca A; Stoccoro S; Landini I; Mini E; Massai L; Ferraro G; Merlino A; Messori L; Cinellu MA
Dalton Trans; 2016 Jan; 45(2):579-90. PubMed ID: 26609781
[TBL] [Abstract][Full Text] [Related]
49. Fresh platinum complexes with promising antitumor activity.
Wang X
Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
[TBL] [Abstract][Full Text] [Related]
50. Novel cis-[(NHC)
Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R
Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959
[TBL] [Abstract][Full Text] [Related]
51. Anticancer activity assessment of two novel binuclear platinum (II) complexes.
Shahsavani MB; Ahmadi S; Aseman MD; Nabavizadeh SM; Rashidi M; Asadi Z; Erfani N; Ghasemi A; Saboury AA; Niazi A; Bahaoddini A; Yousefi R
J Photochem Photobiol B; 2016 Aug; 161():345-54. PubMed ID: 27289447
[TBL] [Abstract][Full Text] [Related]
52. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
[TBL] [Abstract][Full Text] [Related]
53. Cytotoxicity and cellular response mechanisms of water-soluble platinum(II) complexes of lidocaine and phenylcyanamide derivatives.
Tabrizi L; Chiniforoshan H
Biometals; 2017 Feb; 30(1):59-70. PubMed ID: 27995355
[TBL] [Abstract][Full Text] [Related]
54. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of platinum-ethacrynic acid conjugates in the treatment of mesothelioma.
Zanellato I; Bonarrigo I; Sardi M; Alessio M; Gabano E; Ravera M; Osella D
ChemMedChem; 2011 Dec; 6(12):2287-93. PubMed ID: 22025407
[TBL] [Abstract][Full Text] [Related]
56. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
57. Rapid fluorescence-based reporter-gene assays to evaluate the cytotoxicity and antitumor drug potential of platinum complexes.
Sandman KE; Marla SS; Zlokarnik G; Lippard SJ
Chem Biol; 1999 Aug; 6(8):541-51. PubMed ID: 10421759
[TBL] [Abstract][Full Text] [Related]
58. Chemical and cellular investigations of trans-ammine-pyridine-dichlorido-platinum(II), the likely metabolite of the antitumor active cis-diammine-pyridine-chorido-platinum(II).
Xu D; Min Y; Cheng Q; Shi H; Wei K; Arnesano F; Natile G; Liu Y
J Inorg Biochem; 2013 Dec; 129():15-22. PubMed ID: 24008133
[TBL] [Abstract][Full Text] [Related]
59. Platinum(IV) complexes conjugated with chalcone analogs as dual targeting anticancer agents: In vitro and in vivo studies.
Huang X; Liu Z; Wang M; Yin X; Wang Y; Dai L; Wang H
Bioorg Chem; 2020 Dec; 105():104430. PubMed ID: 33171407
[TBL] [Abstract][Full Text] [Related]
60. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
